1. Home
  2. SWTX vs GRBK Comparison

SWTX vs GRBK Comparison

Compare SWTX & GRBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SWTX
  • GRBK
  • Stock Information
  • Founded
  • SWTX 2017
  • GRBK 2006
  • Country
  • SWTX United States
  • GRBK United States
  • Employees
  • SWTX N/A
  • GRBK N/A
  • Industry
  • SWTX Biotechnology: Pharmaceutical Preparations
  • GRBK Homebuilding
  • Sector
  • SWTX Health Care
  • GRBK Consumer Discretionary
  • Exchange
  • SWTX Nasdaq
  • GRBK Nasdaq
  • Market Cap
  • SWTX 3.0B
  • GRBK 2.4B
  • IPO Year
  • SWTX 2019
  • GRBK N/A
  • Fundamental
  • Price
  • SWTX $37.92
  • GRBK $55.74
  • Analyst Decision
  • SWTX Strong Buy
  • GRBK Hold
  • Analyst Count
  • SWTX 5
  • GRBK 3
  • Target Price
  • SWTX $72.40
  • GRBK $65.50
  • AVG Volume (30 Days)
  • SWTX 2.2M
  • GRBK 348.1K
  • Earning Date
  • SWTX 05-01-2025
  • GRBK 04-30-2025
  • Dividend Yield
  • SWTX N/A
  • GRBK N/A
  • EPS Growth
  • SWTX N/A
  • GRBK 37.62
  • EPS
  • SWTX N/A
  • GRBK 8.45
  • Revenue
  • SWTX $191,589,000.00
  • GRBK $2,098,943,000.00
  • Revenue This Year
  • SWTX $85.98
  • GRBK $5.34
  • Revenue Next Year
  • SWTX $69.16
  • GRBK $7.55
  • P/E Ratio
  • SWTX N/A
  • GRBK $6.60
  • Revenue Growth
  • SWTX 3417.33
  • GRBK 18.07
  • 52 Week Low
  • SWTX $28.21
  • GRBK $50.57
  • 52 Week High
  • SWTX $62.00
  • GRBK $84.66
  • Technical
  • Relative Strength Index (RSI)
  • SWTX 39.33
  • GRBK 45.25
  • Support Level
  • SWTX $36.08
  • GRBK $54.21
  • Resistance Level
  • SWTX $38.77
  • GRBK $57.76
  • Average True Range (ATR)
  • SWTX 3.21
  • GRBK 3.03
  • MACD
  • SWTX -0.17
  • GRBK -0.09
  • Stochastic Oscillator
  • SWTX 36.05
  • GRBK 56.38

About SWTX SpringWorks Therapeutics Inc.

SpringWorks Therapeutics Inc is a clinical stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers.

About GRBK Green Brick Partners Inc.

Green Brick Partners Inc is a homebuilding and land development company. It acquires and develops land, as well as provides land and construction financing to its controlled builders. The company has three reportable segments: builder operations central, builder operations southeast, and land development. The majority of the company's revenue is generated from the builder operations central segment which is entirely the operations of builders in Texas. The company is engaged in various aspects of the homebuilding process, including land acquisition and development, entitlements, design, construction, marketing, sales, and brand image creation. In addition to homebuilding, the company provides home financing services, such as mortgage and title.

Share on Social Networks: